Cascade Pharmaceuticals, Inc

Drugs for medical purposes; organotherapy preparations; biological preparations for medical purposes; medicines for human purposes; chemical preparations for medical purposes; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes.

Drugs for medical purposes; organotherapy preparations; biological preparations for medical purposes; medicines for human purposes; chemical preparations for medical purposes; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes.

Medicines for human purposes; diagnostic preparations for medical purposes; drugs for medical purposes; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; chemical preparations for medical purposes; opotherapy preparations; biological preparations for medical purposes; medicine cases, portable, filled; stem cells for medical purposes.

Medicines for human purposes; diagnostic preparations for medical purposes; drugs for medical purposes; bacteriological preparations for medical and veterinary use; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; chemical preparations for medical purposes; opotherapy preparations; biological preparations for medical purposes; medicine cases, portable, filled; stem cells for medical purposes; chemical reagents for medical or veterinary purposes.

Pharmaceutical preparations for the treatment of immune, inflammatory and metabolic diseases,namely, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), cholestatic liver disease, inflammatory bowel disease, chronic kidney disease for medical purposes; organotherapy preparations; enzyme preparations for medical purposes; medicines for the treatment of immune, inflammatory and metabolic diseases, namely, nonalcoholic fatty liver disease (NAFLD) andnonalcoholic steatohepatitis (NASH), cholestatic liver disease, inflammatory bowel disease, chronic kidney disease, for human purposes; chemical preparations for medical purposes, namely for immune, inflammatory and metabolic diseases,particularly, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), cholestatic liver disease, inflammatory bowel disease, chronic kidney disease; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes

Pharmaceutical preparations for the treatment of immune, inflammatory and metabolic diseases, namely, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), cholestatic liver disease, inflammatory bowel disease, chronic kidney disease for medical purposes; organotherapy preparations; enzyme preparations for medical purposes; medicines for the treatment of immune, inflammatory and metabolic diseases, namely, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), cholestatic liver disease, inflammatory bowel disease, chronic kidney disease, for human purposes; chemical preparations for medical purposes, namely for immune, inflammatory and metabolic diseases, particularly, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), cholestatic liver disease, inflammatory bowel disease, chronic kidney disease; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; the foregoing featuring farnesoid X receptor agonists